Concepts (176)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cytoskeletal Proteins | 2 | 2022 | 13 | 1.420 |
Why?
|
| Osteoarthritis | 5 | 2022 | 289 | 1.000 |
Why?
|
| Cartilage, Articular | 5 | 2022 | 279 | 0.940 |
Why?
|
| Muscle Proteins | 2 | 2022 | 23 | 0.840 |
Why?
|
| Chondrocytes | 3 | 2022 | 103 | 0.800 |
Why?
|
| Osteoclasts | 4 | 2016 | 20 | 0.770 |
Why?
|
| Temporomandibular Joint | 1 | 2022 | 17 | 0.760 |
Why?
|
| Mice | 13 | 2022 | 1249 | 0.710 |
Why?
|
| Animals | 17 | 2022 | 3311 | 0.680 |
Why?
|
| Maf Transcription Factors, Large | 1 | 2020 | 2 | 0.650 |
Why?
|
| Insulin-Secreting Cells | 1 | 2020 | 11 | 0.650 |
Why?
|
| Osteoblasts | 2 | 2016 | 52 | 0.620 |
Why?
|
| beta Catenin | 1 | 2020 | 58 | 0.620 |
Why?
|
| Up-Regulation | 3 | 2020 | 144 | 0.570 |
Why?
|
| Bone Remodeling | 2 | 2015 | 48 | 0.550 |
Why?
|
| Activating Transcription Factor 4 | 2 | 2013 | 2 | 0.520 |
Why?
|
| Hypoxia-Inducible Factor-Proline Dioxygenases | 1 | 2016 | 1 | 0.520 |
Why?
|
| Procollagen-Proline Dioxygenase | 1 | 2016 | 3 | 0.520 |
Why?
|
| Calcification, Physiologic | 1 | 2016 | 18 | 0.510 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2016 | 31 | 0.510 |
Why?
|
| Muscular Atrophy | 1 | 2015 | 11 | 0.460 |
Why?
|
| Amyotrophic Lateral Sclerosis | 1 | 2015 | 22 | 0.450 |
Why?
|
| Sweetening Agents | 1 | 2013 | 5 | 0.420 |
Why?
|
| Fructose | 1 | 2013 | 4 | 0.420 |
Why?
|
| Multiple Myeloma | 1 | 2013 | 18 | 0.410 |
Why?
|
| Lipid Metabolism | 1 | 2013 | 33 | 0.410 |
Why?
|
| Hypertriglyceridemia | 1 | 2013 | 20 | 0.410 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2013 | 57 | 0.400 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2013 | 114 | 0.400 |
Why?
|
| Mice, Transgenic | 3 | 2020 | 176 | 0.390 |
Why?
|
| Osteolysis | 1 | 2013 | 113 | 0.380 |
Why?
|
| Liver | 1 | 2013 | 141 | 0.380 |
Why?
|
| Mice, Knockout | 5 | 2020 | 283 | 0.350 |
Why?
|
| Lactoferrin | 3 | 2013 | 9 | 0.310 |
Why?
|
| Intervertebral Disc | 3 | 2013 | 114 | 0.280 |
Why?
|
| Cell Proliferation | 2 | 2020 | 165 | 0.260 |
Why?
|
| Mice, Inbred C57BL | 2 | 2020 | 364 | 0.250 |
Why?
|
| Signal Transduction | 4 | 2020 | 402 | 0.240 |
Why?
|
| Aggrecans | 2 | 2022 | 51 | 0.210 |
Why?
|
| Cells, Cultured | 5 | 2020 | 472 | 0.210 |
Why?
|
| Low Back Pain | 2 | 2015 | 128 | 0.190 |
Why?
|
| Phenotype | 2 | 2020 | 261 | 0.180 |
Why?
|
| Gene Expression | 2 | 2020 | 179 | 0.180 |
Why?
|
| Protein Stability | 1 | 2020 | 4 | 0.160 |
Why?
|
| Islets of Langerhans | 1 | 2020 | 3 | 0.160 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2020 | 19 | 0.160 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2020 | 11 | 0.160 |
Why?
|
| Metformin | 1 | 2020 | 15 | 0.160 |
Why?
|
| Gene Knockdown Techniques | 1 | 2020 | 41 | 0.160 |
Why?
|
| Neoplasm Proteins | 1 | 2020 | 52 | 0.160 |
Why?
|
| Insulin Resistance | 1 | 2020 | 48 | 0.160 |
Why?
|
| Insulin | 1 | 2020 | 79 | 0.160 |
Why?
|
| Gene Editing | 1 | 2019 | 7 | 0.150 |
Why?
|
| Synovial Membrane | 3 | 2016 | 47 | 0.150 |
Why?
|
| CRISPR-Cas Systems | 1 | 2019 | 11 | 0.150 |
Why?
|
| MicroRNAs | 1 | 2019 | 37 | 0.150 |
Why?
|
| Membrane Proteins | 1 | 2020 | 151 | 0.150 |
Why?
|
| Humans | 10 | 2020 | 23569 | 0.140 |
Why?
|
| Male | 4 | 2020 | 12776 | 0.140 |
Why?
|
| Female | 4 | 2020 | 13266 | 0.140 |
Why?
|
| Arthralgia | 2 | 2016 | 108 | 0.130 |
Why?
|
| Intervertebral Disc Degeneration | 2 | 2015 | 74 | 0.130 |
Why?
|
| Gene Deletion | 1 | 2016 | 39 | 0.130 |
Why?
|
| Interleukin-1 | 2 | 2013 | 48 | 0.130 |
Why?
|
| Organ Size | 1 | 2016 | 86 | 0.130 |
Why?
|
| Lipopolysaccharides | 2 | 2013 | 87 | 0.130 |
Why?
|
| Protein Kinase C-delta | 1 | 2016 | 10 | 0.120 |
Why?
|
| Axons | 1 | 2016 | 24 | 0.120 |
Why?
|
| Fibroblast Growth Factor 2 | 2 | 2013 | 10 | 0.120 |
Why?
|
| Osteoarthritis, Spine | 1 | 2015 | 5 | 0.120 |
Why?
|
| Homeostasis | 2 | 2013 | 65 | 0.120 |
Why?
|
| Zygapophyseal Joint | 1 | 2015 | 27 | 0.120 |
Why?
|
| Superoxide Dismutase-1 | 1 | 2015 | 2 | 0.120 |
Why?
|
| RANK Ligand | 1 | 2015 | 2 | 0.120 |
Why?
|
| Mutation, Missense | 1 | 2015 | 24 | 0.120 |
Why?
|
| Superoxide Dismutase | 1 | 2015 | 19 | 0.110 |
Why?
|
| Scoliosis | 1 | 2015 | 34 | 0.110 |
Why?
|
| Joint Capsule | 1 | 2015 | 47 | 0.110 |
Why?
|
| Bone Marrow Cells | 1 | 2015 | 50 | 0.110 |
Why?
|
| Glycoproteins | 1 | 2015 | 42 | 0.110 |
Why?
|
| TNF Receptor-Associated Factor 6 | 1 | 2014 | 1 | 0.110 |
Why?
|
| Spondylolisthesis | 1 | 2015 | 41 | 0.110 |
Why?
|
| RNA, Messenger | 1 | 2015 | 285 | 0.110 |
Why?
|
| Cell Differentiation | 1 | 2015 | 125 | 0.110 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2014 | 26 | 0.110 |
Why?
|
| Bone Development | 1 | 2014 | 30 | 0.110 |
Why?
|
| Bone and Bones | 1 | 2015 | 109 | 0.110 |
Why?
|
| Bone Density | 1 | 2015 | 139 | 0.110 |
Why?
|
| Receptor Activator of Nuclear Factor-kappa B | 1 | 2013 | 1 | 0.110 |
Why?
|
| Chromones | 1 | 2013 | 9 | 0.110 |
Why?
|
| Neoplasm Transplantation | 1 | 2013 | 13 | 0.110 |
Why?
|
| Morpholines | 1 | 2013 | 14 | 0.100 |
Why?
|
| Heterografts | 1 | 2013 | 16 | 0.100 |
Why?
|
| Acetyl-CoA Carboxylase | 1 | 2013 | 1 | 0.100 |
Why?
|
| Fatty Acid Synthase, Type I | 1 | 2013 | 1 | 0.100 |
Why?
|
| Sterol Regulatory Element Binding Protein 1 | 1 | 2013 | 2 | 0.100 |
Why?
|
| Mice, SCID | 1 | 2013 | 40 | 0.100 |
Why?
|
| PPAR gamma | 1 | 2013 | 13 | 0.100 |
Why?
|
| Tumor Cells, Cultured | 1 | 2013 | 128 | 0.100 |
Why?
|
| Bone Morphogenetic Protein 7 | 1 | 2013 | 28 | 0.100 |
Why?
|
| Enzyme Inhibitors | 1 | 2013 | 115 | 0.100 |
Why?
|
| Cattle | 4 | 2013 | 112 | 0.100 |
Why?
|
| Carrier Proteins | 1 | 2013 | 89 | 0.100 |
Why?
|
| Receptors, Fibroblast Growth Factor | 1 | 2012 | 3 | 0.100 |
Why?
|
| Nerve Growth Factor | 3 | 2019 | 39 | 0.100 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2012 | 18 | 0.100 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2013 | 91 | 0.090 |
Why?
|
| Osteoarthritis, Knee | 1 | 2016 | 299 | 0.090 |
Why?
|
| Muscle, Skeletal | 1 | 2015 | 337 | 0.090 |
Why?
|
| Disease Models, Animal | 3 | 2020 | 528 | 0.090 |
Why?
|
| Lumbar Vertebrae | 1 | 2015 | 358 | 0.080 |
Why?
|
| Gene Expression Regulation | 3 | 2020 | 233 | 0.080 |
Why?
|
| Proteoglycans | 3 | 2013 | 120 | 0.070 |
Why?
|
| Interleukin-1beta | 2 | 2019 | 38 | 0.060 |
Why?
|
| Receptor, trkA | 2 | 2016 | 10 | 0.060 |
Why?
|
| Ganglia, Spinal | 2 | 2016 | 56 | 0.060 |
Why?
|
| Vascular Endothelial Growth Factor A | 2 | 2015 | 67 | 0.050 |
Why?
|
| Organ Culture Techniques | 2 | 2013 | 12 | 0.050 |
Why?
|
| Cytokines | 2 | 2015 | 206 | 0.050 |
Why?
|
| Matrix Metalloproteinases | 2 | 2013 | 19 | 0.050 |
Why?
|
| Mice, Obese | 1 | 2020 | 4 | 0.040 |
Why?
|
| Hypoglycemic Agents | 1 | 2020 | 35 | 0.040 |
Why?
|
| Random Allocation | 1 | 2020 | 109 | 0.040 |
Why?
|
| Synoviocytes | 1 | 2019 | 2 | 0.040 |
Why?
|
| Peptide Hydrolases | 1 | 2019 | 7 | 0.040 |
Why?
|
| Menisci, Tibial | 1 | 2020 | 97 | 0.040 |
Why?
|
| Core Binding Factor Alpha 1 Subunit | 1 | 2019 | 30 | 0.040 |
Why?
|
| Matrix Metalloproteinase 13 | 1 | 2019 | 19 | 0.040 |
Why?
|
| Sensitivity and Specificity | 1 | 2020 | 453 | 0.040 |
Why?
|
| Disease Progression | 1 | 2020 | 530 | 0.040 |
Why?
|
| Aged | 3 | 2015 | 7586 | 0.030 |
Why?
|
| Middle Aged | 3 | 2015 | 8155 | 0.030 |
Why?
|
| Sensory Receptor Cells | 1 | 2016 | 9 | 0.030 |
Why?
|
| Coculture Techniques | 1 | 2015 | 30 | 0.030 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2015 | 37 | 0.030 |
Why?
|
| Blotting, Western | 1 | 2015 | 132 | 0.030 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2015 | 134 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2015 | 315 | 0.030 |
Why?
|
| Ubiquitination | 1 | 2014 | 15 | 0.030 |
Why?
|
| Bone Diseases, Metabolic | 1 | 2014 | 16 | 0.030 |
Why?
|
| Immunohistochemistry | 1 | 2015 | 341 | 0.030 |
Why?
|
| HEK293 Cells | 1 | 2014 | 61 | 0.030 |
Why?
|
| Mutation | 1 | 2016 | 330 | 0.030 |
Why?
|
| Cadaver | 1 | 2015 | 305 | 0.030 |
Why?
|
| NF-kappa B | 1 | 2014 | 104 | 0.030 |
Why?
|
| Cell Line | 1 | 2014 | 250 | 0.030 |
Why?
|
| Bone Resorption | 1 | 2014 | 76 | 0.030 |
Why?
|
| Rats | 1 | 2015 | 624 | 0.030 |
Why?
|
| Macrophages | 1 | 2014 | 91 | 0.030 |
Why?
|
| Smad6 Protein | 1 | 2013 | 2 | 0.030 |
Why?
|
| Hexuronic Acids | 1 | 2013 | 6 | 0.030 |
Why?
|
| Glucuronic Acid | 1 | 2013 | 6 | 0.030 |
Why?
|
| Alginates | 1 | 2013 | 7 | 0.030 |
Why?
|
| Cell Survival | 1 | 2013 | 100 | 0.030 |
Why?
|
| Drug Synergism | 1 | 2013 | 38 | 0.030 |
Why?
|
| Collagen Type II | 1 | 2013 | 19 | 0.030 |
Why?
|
| Rabbits | 1 | 2013 | 169 | 0.030 |
Why?
|
| Cell Count | 1 | 2013 | 72 | 0.030 |
Why?
|
| SOX9 Transcription Factor | 1 | 2013 | 14 | 0.030 |
Why?
|
| Endopeptidases | 1 | 2013 | 21 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2013 | 131 | 0.020 |
Why?
|
| Fibroblasts | 1 | 2013 | 50 | 0.020 |
Why?
|
| MAP Kinase Signaling System | 1 | 2013 | 35 | 0.020 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2013 | 55 | 0.020 |
Why?
|
| Inflammation Mediators | 1 | 2013 | 60 | 0.020 |
Why?
|
| CD11b Antigen | 1 | 2012 | 13 | 0.020 |
Why?
|
| Species Specificity | 1 | 2012 | 34 | 0.020 |
Why?
|
| Neovascularization, Physiologic | 1 | 2012 | 23 | 0.020 |
Why?
|
| Toll-Like Receptor 2 | 1 | 2012 | 32 | 0.020 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2012 | 64 | 0.020 |
Why?
|
| ADAM Proteins | 1 | 2012 | 40 | 0.020 |
Why?
|
| Adult | 2 | 2015 | 7178 | 0.020 |
Why?
|
| Knee Joint | 1 | 2016 | 577 | 0.020 |
Why?
|
| Inflammation | 1 | 2012 | 237 | 0.020 |
Why?
|
| Young Adult | 1 | 2015 | 1747 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2015 | 3770 | 0.020 |
Why?
|